Abstract
Background
Proteoglycans (PGs) have long been known to be important to the functioning of the intervertebral disc. The most common PG is aggrecan, but there are also small leucine-rich proteoglycans (SLRPs) which constitute only a small percentage of the total PGs. However, they have many important functions, including organising the collagen, protecting it from degradation and attracting growth factors to the disc. We have examined how the core proteins of these molecules vary in intervertebral discs from patients with different pathologies.
Methods
Discs were obtained from patients with scoliosis (n=7, 19–53y), degenerative disc disease (DDD) (n=6, 35–51y) and herniations (n=5, 33–58y). Proteoglycans were extracted and the SLRPs (biglycan, decorin, fibromodulin, keratocan and lumican) were characterised via Western blotting following enzymatic digestion with chondroitinase ABC and keratanase.
Results
At least some SLRPs were present in all the discs studied. In addition to the presence of intact SLRP core proteins there was evidence of fragmentation of all the core proteins but especially of biglycan, fibromodulin and keratocan. Biglycan and keratocan were present in the majority of samples with biglycan being highly fragmented in the majority and keratocan usually present as 2 molecular weight bands. Fibromodulin was present in all samples except for 1 scoliotic disc and usually showed a high degree of fragmentation. The intact core protein of lumican was detected in all samples and was only present as a fragment in one of the older scoliosis samples. Decorin was present in a few samples of which half showed fragmentation.
Conclusion
Although the number of samples investigated so far is low, fragmentation of these SLRP molecules appears common in the pathological intervertebral disc. These findings are useful not only in helping unravel pathways of disc degeneration, but may also provide early biomarkers of the different pathologies.
Conflicts of Interest
None
Source of Funding
None
Acknowledgements: MRC and AR UK for financial support of SR & SO.
